Autocrine/Paracrine IL-15 That Is Required for Type I IFN-Mediated Dendritic Cell Expression of MHC Class I-Related Chain A and B Is Impaired in Hepatitis C Virus Infection

Journal of Immunology

Volumn 171, Issue 10, 2003, Pages 5423-5429

  Jinushi, Masahisa ^a   Takehara, Tetsuo ^a   Tatsumi, Tomohide ^a   Kanto, Tatsuya ^a   Groh, Veronika ^b   Spies, Thomas ^b   Suzuki, Takahiro ^a   Miyagi, Takuya ^a   Hayashi, Norio ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE ANTIBODY; INTERFERON; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANTIGEN EXPRESSION; ARTICLE; AUTOCRINE EFFECT; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE INDUCTION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; MONOCYTE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL;

EID: 0242410962     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.10.5423     Document Type: Article

References (47)

1. Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187.
2. Biron, C. A., K. B. Nguyen, G. C. Pien, L. P. Cousens, and P. Salazar-Mather. 1999. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17:189.
3. Fernandez, N. C., A. Lozier, C. Flament, P. Ricciardi-Castagnoli, D. Bellet, M. Suter, M. Perricaudet, T. Tursz, E. Maraskovsky, and L. Zitvogel. 1999. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5:405.
4. + cell-derived NK cell cytotoxicity by dendritic cells. J. Immunol. 166:1590.
5. + blood dendritic cells enhance NK cell-mediated cytotoxicity. Eur. J. Immunol. 31:2633.
6. Gerosa, F., B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195:327.
7. Piccioli, D., S. Sbrana, E. Melandri, and N. M. Valiance. 2002. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 3:335.
8. Ferlazzo, G., M. L. Tsang, L. Moretta, G. Meliole, R. M. Steinman, and C. Munz. 2002. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195:343.
9. Andrewa, A., A. A. Scalzo, W. M. Yokoyama, M. J. Smyth, and M. A. Degli-Esposti. 2003. Functional interactions between dendritic cells and NK cells during viral infection. Nat. Immun. 4:175.
10. Ferlazzo, G., B. Morandi, A. D'Agostino, R. Meazza, G. Meliolo, A. Morreta, and L. Morreta. 2003. The interaction between NK cells and dendritic cells in bacterial infections results in repid induction of NK cell activation and in the lysis of uninfected dendritic cells. Eur. J. Immunol. 33:306.
11. Bauer, S., V. Groh, J. Wu, A. Steinle, J. H. Phillips, L. L. Lanier, and T. Spies. 1999. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285:727.
12. Groh, V., R. Rhinehart, H. Secrist, S. Bauer, K. H. Grabstein. and T. Spies. 1999. Broad tumor-associated expression and recognition by tumor-derived T cells of MICA and MICB. Proc. Natl. Acad. Sci. USA 96:6879.
13. Das, H., V. Groh, C. Kujil, M. Sugita, C. T. Morita, T. Spies, and J. F. Bukowski. 2001. MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function. Immunity 15:83.
14. Jinushi, M., T. Takehara, T. Tatsumi, T. Kanto, V. Groh, T. Spies, R. Kimura, T. Miyagi, K. Mochizuki, Y. Sasaki, and N. Hayashi. 2003. Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int. J. Cancer 104:354.
15. Jinushi, M., T. Takehara, T. Kanto, T. Tatsumi, V. Groh, T. Spies, T. Miyagi. T. Suzuki, Y. Sasaki, and N. Hayashi. 2003. Critical role of MHC class I-related chain A and B expression on IFNα-stimulated dendritic cells in NK cell activation: impairment in chronic hepatitis C infection. J. Immunol. 170:1249.
16. Liang, J. T., B. Rhermann, L. B. Sheeff, and J. H. Hoofnagle. 2000. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann. Intern. Med. 132:296.
17. Chander, G., A. S. Sulkowski, M. W. Jenckes, M. S. Torbenson, H. F. Herlong, E. B. Bass, and K. Gebo. 2002. Treatment of chronic hepatitis C: a systematic review: National Institutes of Health Consensus Development Conference: management of hepatitis C: 2002. Hepatology 36:S135.
18. Cooper, S., A. L. Erickson, E. J. Adams, J. Kansopon, A. J. Weiner, D. Y. Chien, M. Houghton, P. Parham, and C. M. Walker. 1999. Analysis of a successful immune response against hepatitis C virus. Immunity 10:439.
19. Cherry, A., and F. V. Chisari. 1999. Pathogenesis of chronic hepatitis C: immnological features of hepatic injury and viral persistence. Hepatology 30:595.
20. Lohr, H. F., D. Schmitz, M. Arenz, S. Weyer, G. Gerken, and K. H. Meyer zum Buschenfelde. 1998. The cellular immune responses induced in the follow-up of interferon-α treated patients with chronic hepatitis C may determine the therapy outcome. J. Hepatol. 28:524.
21. + T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology 32:962.
22. Corado, J., F. Toro, H. Rivera, N. E. Bianco, L. Deibis, and J. B. deSancis. 1997. Impairment of natural killer (NK) cytotoxic activity in hepatitis C (HCV) infection. Clin. Exp. Immunol. 109:451.
23. Crotta, S., A. Stilla, A. Wack, A. D'Andrea, S. Nuti, U. D'Oro, M. Mosca, F. Filliponi, R. M. Brunetto, F. Bonino, et al. 2002. Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein. J. Exp. Med. 195:35.
24. Banchereau, J., B. Francine, C. Christophe, D. Jean, L. Serge, Y. J. Liu, P. Bali, and P. Karolina. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.
25. Santini, S. M., C. Lapenta, M. Logozzi, S. Parlato, M. Spada, T. D. Pucchio, and F. Belardelli. 2000. Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in vivo in Hu-PBL-SCID mice. J. Exp. Med. 10:1777.
26. Tatsumi, T., T. Takehara, T. Kanto, T. Miyagi, N. Kuzushita, Y. Sugimoto, M. Jinushi, A. Kasahara, Y. Sasaki, M. Hori, and N. Hayashi. 2001. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma. Cancer Res. 61:75663.
27. + T cell response following vaccination with peptide-pulsed dendritic cells. J. Immunol. 169:4928.
28. Ju, D. W., Q. Tao, G. Lou, M. Bai, L. He, Y. Yang, and X. Cao. 2001. Interleukin 18 transfection enhances antitumor immunity by dendritic cell-tumor cell conjugates. Cancer Res. 61:3735.
29. Groh, V., A. Steinle, S. Bauer, and T. Spies. 1998. Recognition of stress-induced molecules by intestinal epithelium γδ T cells. Science 279:1737.
30. Yamada, Y., K. Sugawara, T. Hata, K. Tsuruta, R. Moriuchi, T. Maeda, S. Atogami, K. Murata, K. Fujimoto, T. Konihiro, et al. 1998. Interleukin-15 (IL-15) can replace the IL-2 signal in IL-2-dependent adult T-cell leukemia (ATL) cell lines: expression of IL-15 receptor α on ATL cells. Blood 11:4265.
31. Tayebi, H., M. Lienard, P. Billot, P. Tiberghien, P. Herbe, and E. Robinet. 1999. Detection of intracellular cytokines in citrated whole blood or marrow samples by flow cytometry. J. Immunol. Methods 229:121.
32. Komatsu-Wakui, M., K. Tokunaga, Y. Ishikawa, K. Kashiwase, S. Moriyama, N. Tsuchiya, H. Ando, T. Shiina, D. E. Geraghty, H. Inoko, and T. Juji. 1999. MIC-A polymorphism in Japanese and a MIC-A-MIC-B null haplotype. Immunogenetics 49:620.
33. Mattei, F., G. Schiavoni, F. Belardelli, and D. Tough. 2001. IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J. Immunol. 167:1179.
34. Fehniger, T. A., and M. A. Caligiuri. 2001. Interleukin 15: biology and relevance to human disease. Blood 97:14.
35. Dubois, S., F. Magrangeas, P. Lehours, S. Raher, J. Bernard, O. Boisteau, S. Leroy, M. Minvielle, A. Godard, and Y. Jacques. 1999. Natural splicing of exon 2 of human interleukin-15 receptor α chain mRNA results in a shortened form with a distinct pattern of expression. J. Biol. Chem. 38:26978.
36. Nguyen, K. B., T. P. Salazar-Mather, M. Y. Dalod, J. B. Van Deusen, X.-q. Wei, F. Y. Liew, M. A. Caligiuri, J. E. Durbin, and C. A. Biron. 2002. Coordinated and distinct roles for IFNαβ, IL-12 and IL-15 regulation of NK cell response to viral infection. J. Immunol. 169:4279.
37. Gary-Gouy, H., P. Lebon, and A. H. Dalloul. 2002. Type I interferon production by plasmacytoid dendritic cells and monocytes is triggered by viruses, but the level of production is controlled by distinct cytokines. J. Interferon Cytokine Res. 22:653.
38. Lodolce, J. P., D. L. Boone, S. Chai, R. E. Swain, T. Dassopoulos, S. Trettin, and A. Ma. 1998. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9:669.
39. Ranson, T., C. A. Vosshenrich, E. Corcuff, O. Richard, V. Laloux, A. Lehuen, and J. P. Di Santo. 2003. IL-15 availability conditions homeostasis of peripheral natural killer T cells. Proc. Natl. Acad. Sci. USA 100:2663.
40. Schluns, K. S., K. Williams, A. Ma, X. X. Zheng, and L. Lefrancois. 2002. Requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J. Immunol. 168:4827.
41. Becker, T. C., E. J. Wherry, D. Boone, K. Murali-Krishna, R. Antia, A. Ma, and R. Ahmed. 2002. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J. Exp. Med. 195:1541.
42. Mahamadzadeh, M., F. Berard, G. Essert, C. Chalouni, B. Pulendran, J. Davoust, G. Bridges, A. K. Palucka, and J. Bachereau. 2001. Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells. J. Exp. Med. 194:1013.
43. Ohteki, T., K. Suzue, C. Maki, T. Ota, and S. Koyasu. 2001. Critical role of IL-15-IL-15R for antigen-presenting cell functions in the innate immune response. Nat. Immun. 12:1138.
44. Ogasawara, K., S. Hida, N. Azimi, Y. Tagaya, T. Sato, T. Yokochi-Fukuda, T. A. Waldmann, and T. Taniguchi. 1998. Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 391:700.
45. Mariner, J. M., Y. Mamane, J. Hiscott, T. A. Waldmann, and N. Azumi. 2002. IFN regulatory factor 4 participates in the human T cell lymphotropic virus type 1-mediated activation of the IL-15 receptor promotor. J. Immunol. 168:5667.
46. Heim, M., D. Maradpour, and H. E. Blum. 1999. Expression of hepatitis C virus proteins inhibits signal transduction through the JAK-STAT pathway. J. Virol. 73:8469.
47. Groh, V., R. Rhinehart, J. Randolph-Habecker, M. S. Topp, S. R. Riddell, and T. Spies. 2001. Costimulation of CD8αβ T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immun. 2:255.